The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Agoston Gyula SzaboJonathan ThorsenKatrine Fladeland IversenMette Bøegh LevringBirgitte PreissCarsten HellebergMarie Fredslund BreinholtNiels Emil Ulrich HermansenLise Mette Rahbek GjerdrumSøren Thorgaard BønløkkeKatrine NielsenEigil KjeldsenElena Manuela TeodorescuMarveh DokhiEva KurtCasper Nørgaard StrandholdtMette Klarskov AndersenAnnette Juul VangstedPublished in: American journal of hematology (2021)